Interest in Precision Medicine Grows, But Reimbursements Slow
By Andrew Joseph,
Stat News
| 12. 23. 2015
Untitled Document
Precision medicine, in which drugs are matched to individual patients, has generated tons of buzz, from patient organizations all the way to the White House. But insurers have been grappling with whether to pay for the genetic tests that often guide such treatments, and that uncertainty has had ripple effects through the biotech companies working to develop them.
The case of Foundation Medicine, based in Cambridge, Mass., demonstrates the quest companies sometimes have to undertake to get their products covered, a process complicated when that product is a cutting-edge technology insurers aren’t sure how to assess.
Foundation analyzes the genes of a patient’s tumor to identify what’s driving the cancer and, from that, to determine what treatment will work best. The company announced this week that UnitedHealth Group had started covering its genetic test for patients with a certain lung cancer. That decision, by the country’s largest private health insurer, represents a milestone for the company as it looks to strike deals with more insurers.
Read more...
Image via Flickr.
Related Articles
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
By Jorge Barrera and Rachel Houlihan, CBC | 04.09.2024
A Canadian DNA laboratory knowingly delivered prenatal paternity test results that routinely identified the wrong biological fathers — ruling out the real dads — and left a trail of shattered lives around the globe, a CBC News investigation has found...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Carey Gillan, UnSpun | 03.18.2024
A Mexican standoff with the United States turned into a Mexican smack-down this month with the release of Mexico’s formal rebuttal to US efforts to overturn limits Mexico has ordered on the use of genetically modified (GM) corn and the...